Novartis | NVS - Despesa De Juros Sobre A Dívida

Preço das Ações
146.89
Mudança Diária
-1.09 -0.74%
Mensal
-4.59%
Anual
28.48%
Q2 Previsão
142.62




Despesa De Juros Sobre A Dívida Alterar Data
AbbVie USD 645M 69M 2026-03
Amgen USD 657M 4M 2026-03
AstraZeneca USD 484M 181M 2025-12
Bausch Health Companies USD 397M 15M 2025-12
Biogen USD 72.6M 12.6M 2025-06
Bristol-Myers Squibb USD 411M 21M 2026-03
Canopy Growth CAD 7.34M 1.46M 2025-12
Corcept Therapeutics USD 814.88M 809.46M 2026-03
Drreddys Laboratories INR 944M 127M 2025-12
Eli Lilly USD 114.7M 134.3M 2025-09
Gilead Sciences USD 255M 1000K 2025-12
GlaxoSmithKline GBP 167M 21M 2026-03
Glaxosmithkline GBP 177.95M 6.05M 2025-09
J&J USD 43M 25M 2026-03
Merck USD 479M 67M 2026-03
Novartis USD 304M 23M 2025-12
Novartis USD 281M 8M 2025-09
Pacira USD 3.7M 193K 2026-03
Perrigo USD 10.08B 10.04B 2025-09
Pfizer USD 711M 59M 2025-12
Phibro Animal Health USD 11.91M 191K 2025-12
Prestige Brands USD 10.67M 636K 2025-12
Roche Holding CHF 304M 7.5M 2025-06
Sanofi EUR 178M 203M 2026-03
Sanofi EUR -25M 99.78M 2025-12
Supernus Pharmaceuticals USD 910K 278K 2023-06
Zoetis USD 57M 1000K 2025-12